Industry Symposium by Bayer

IND 23 - Next-Generation Neuroradiology: Your Voyage Begins Now

Focus topic: Options and facts that would move CNS imaging into the next generation. Jubilee papers, learning and flexible dosing in CNS imaging. R&D advancements including preclinical data on the novel GBCA gadoquatrane, AI clinical use cases, and use of AI in CNS imaging.

5 min
Introduction
Nicoletta Emanuela Anzalone, Milano / Italy
Introduction to topic and speakers
12 min
Exploring Gadovist's Legacy: Jubilee Papers on Efficacy and Safety, and Flexible Dosing in Clinical Practice
Alejandro Rovira Cañellas, Barcelona / Spain
1.Recognize the wealth of Gadovist data based on the experience from 100 million administrations over 25 years from clinical studies and publications on the safety and efficacy.

2.Understand the latest concepts in contrast-enhanced diagnostic imaging learning from past experiences to shape current and future practice, empowering radiologists to select the most appropriate dose for their patients.

12 min
The Future of CNS Imaging: A Comprehensive Review of Clinical AI Applications
Jose Luis Munuera del Cerro, Barcelona / Spain
1.Learn the importance of clear AI clinical use cases and their implications in the development of AI solutions and its implementation.

2.Review the most common and relevant AI clinical use cases for CNS, such as stroke, bleeding, fractures, skull and spine lesions, MS, and dementia.

3.Examine the impact of these solutions on the radiology workflow and clinical outcomes.

12 min
Harmonizing Contrast Media and AI: Advancements in Image Processing and Dosing Optimization
Johannes Haubold, Essen / Germany
1.Understand the potential synergy between contrast media and AI, exploring how they can complement each other in medical imaging.

2.Explore essential clinical considerations in developing an AI solution in the context of GBCA use.

3.Build a foundational understanding of AI in image processing, specifically in the context of CNS imaging, and recognize opportunities for GBCAs in the era of AI.

12 min
40 Years of MR Contrast Media – Is there Anything New?
Hubertus Pietsch, Berlin / Germany
1.Highlight Bayer´s MR contrast media history.

2.Discuss Bayer's applied MR contrast media research and data on Gd presence.

a.Discuss the findings regarding Gd localization and its relationship to intraepidermal nerve fibers.

b.Describe the results of the large animal study regarding gadolinium presence in the complete brain after administering these agents.

3.Share the latest Bayer innovation in contrast media, including the novel GBCA in clinical development Gadoquatrane and its place in the field of MR contrast agents.

7 min
Q&A
Nicoletta Emanuela Anzalone, Milano / Italy
Answering questions from the audience.

Lectures

1
Introduction

Introduction

05:00Nicoletta Emanuela Anzalone, Milano / IT

2
Exploring Gadovist's Legacy: Jubilee Papers on Efficacy and Safety, and Flexible Dosing in Clinical Practice

Exploring Gadovist's Legacy: Jubilee Papers on Efficacy and Safety, and Flexible Dosing in Clinical Practice

12:00Alejandro Rovira Cañellas, Barcelona / ES

3
The Future of CNS Imaging: A Comprehensive Review of Clinical AI Applications

The Future of CNS Imaging: A Comprehensive Review of Clinical AI Applications

12:00Jose Luis Munuera del Cerro, Barcelona / ES

4
Harmonizing Contrast Media and AI: Advancements in Image Processing and Dosing Optimization

Harmonizing Contrast Media and AI: Advancements in Image Processing and Dosing Optimization

12:00Johannes Haubold, Essen / DE

5
40 Years of MR Contrast Media – Is there Anything New?

40 Years of MR Contrast Media – Is there Anything New?

12:00Hubertus Pietsch, Berlin / DE

6
Q&A

Q&A

07:00Nicoletta Emanuela Anzalone, Milano / IT